Tiny mesoporous silica particles block food enzymes reducing metabolic risk factors and blood sugar levels…
Liu MingMay 4, 2020
Sigrid Therapeutics today announced that the Stockholm Material Hub, a long-term collaboration partner of the…
Liu MingMarch 25, 2020
Sigrid Therapeutics meddelade idag att Stockholm Material Hub, företagets samarbetspartner sedan länge, har säkrat €0,5 miljoner…
Liu MingMarch 25, 2020
New study in mice published in Nanomedicine shows Sigrid’s medical device SiPore15 prevents weight gain…
Liu MingJanuary 15, 2020
Sigrid Therapeutics Reports Significant Blood Sugar Reduction with Excellent Safety Profile in STAR Trial with…
Liu MingSeptember 26, 2019
Stockholm, Sweden, September 5, 2019 – Sigrid Therapeutics AB, an innovative technology company developing a…
Liu MingSeptember 5, 2019
First-in-Class MSP (mesoporous silica particle) based therapy targets blood sugar and other metabolic risk factors.…
MorganJuly 16, 2019